Active Ingredient History

  • Now
Roflumilast is a specific phosphodiesterase type (4PDE4) inhibitor indicated for use as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.   NCATS

  • Mol. Mass: 403.207
  • ALogP: 5.03
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$8.3216 - $12.6636
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-di-chloropyrid-4-yl)benzamide | b9302-107 | by217 | by-217 | byk20869 | byk-20869 | daliresp | daxas | libertek | rof | roflumilast | roflumilastum


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue